GGrantIndex
← Leaderboards

Palo Alto Veterans Instit For Research

Palo Alto, CA

Compare ↔
$230,801,862
Total funding
187
Grants

Funding over time

peak $17.6M · FY2006–25
$20M$15M$10M$5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$230,801,862 · 187

By mechanism

R01$184,345,519 · 120
R21$9,036,931 · 26
U01$8,564,927 · 3
R37$6,802,159 · 3
DP1$5,243,615 · 3
R56$4,510,202 · 12

Investigators at Palo Alto Veterans Instit For Research

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Robert John Wong$2,613,4421 gr2Stephen Waldo$452,5041 gr

Emerging Leaders

6–10 yrs in

1Xinguo Jiang$2,285,3021 gr2David Alan Spain$1,283,3211 gr3Steven H. Woodward$1,107,4002 gr4Olivier David$100,9301 gr

All-Time

Most funded here, all years

1Eugene C Butcher$30,099,00220 gr2Thomas A Rando$25,126,49819 gr3Robert B West$9,786,8527 gr4Jamie M Zeitzer$4,709,0854 gr5Wendy M Murray$4,631,1926 gr6Lindsey Eileen Zimmerman$3,263,4912 gr7Jian Luo$2,995,0992 gr8Robert John Wong$2,613,4421 gr

Largest grants

Targeting Cerebrovascular TGF Signaling in Alzheimer's Disease$2,978,965
RF1 · FY2018 · AG
B Lymphocyte-Mediated Autoimmunity in Pain After Trauma$2,454,998
R01 · FY2020 · NS
Predicting Resilience in the Human Microbiome$1,342,950
R01 · FY2015 · AI
Predicting Resilience in the Human Microbiome$1,235,799
R01 · FY2013 · AI
Predicting Resilience in the Human Microbiome$1,230,418
R01 · FY2014 · AI
Implementation of an Evidence-Based PTSD Treatment in Public Sector Settings$1,185,170
R01 · FY2014 · MH
Predicting Resilience in the Human Microbiome$1,181,796
R01 · FY2016 · AI
Predicting Resilience in the Human Microbiome$1,178,586
R01 · FY2017 · AI
Implementation of an Evidence-Based PTSD Treatment in Public Sector Settings$1,146,759
R01 · FY2011 · MH
Development of an Agonist of the TGF-beta Signaling Pthway to Treat Alzheimer's$1,067,411
U01 · FY2013 · NS
Development of an Agonist of the TGF-beta Signaling Pathway to Treat Alzheimer's$1,040,009
U01 · FY2013 · NS
Implementation of an Evidence-Based PTSD Treatment in Public Sector Settings$1,034,348
R01 · FY2012 · MH
Implementation of an Evidence-Based PTSD Treatment in Public Sector Settings$1,003,510
R01 · FY2013 · MH
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification$869,349
U01 · FY2011 · AI
Development of an Agonist of the TGF-beta Signaling Pthway to Treat Alzheimer's$861,758
U01 · FY2012 · NS
Development of an Agonist of the TGF-beta Signaling Pathway to Treat Alzheimer's$861,758
U01 · FY2012 · NS
A New Muscle-Brain Axis Underlying the Cognitive Benefits of Physical Activity$775,047
R01 · FY2013 · AG
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification$756,353
U01 · FY2009 · AI
Hyposalivation and the Human Oral Microbiome$755,188
R01 · FY2016 · DE
An Integrated Diagnostic Biochip for Point of Care Pathogen Identification$730,719
U01 · FY2010 · AI